| Literature DB >> 19033365 |
Krystyna Mazan-Mamczarz1, Yuki Kuwano, Ming Zhan, Elizabeth J White, Jennifer L Martindale, Ashish Lal, Myriam Gorospe.
Abstract
The ubiquitous RNA-binding protein AUF1 promotes the degradation of some target mRNAs, but increases the stability and translation of other targets. Here, we isolated AUF1-associated mRNAs by immunoprecipitation of (AUF1-RNA) ribonucleoprotein (RNP) complexes from HeLa cells, identified them using microarrays, and used them to elucidate a signature motif shared among AUF1 target transcripts. The predicted AUF1 motif (29-39 nucleotides) contained 79% As and Us, consistent with the AU-rich sequences of reported AUF1 targets. Importantly, 10 out of 15 previously reported AUF1 target mRNAs contained the AUF1 motif. The predicted interactions between AUF1 and target mRNAs were recapitulated in vitro using biotinylated RNAs. Interestingly, further validation of predicted AUF1 target transcripts revealed that AUF1 associates with both the pre-mRNA and the mature mRNA forms. The consequences of AUF1 binding to 10 predicted target mRNAs were tested by silencing AUF1, which elevated the steady-state levels of only four mRNAs, and by overexpressing AUF1, which also lowered the levels of only four mRNAs. In total, we have identified a signature motif in AUF1 target mRNAs, have found that AUF1 also associates with the corresponding pre-mRNAs, and have discovered that altering AUF1 levels alone only modifies the levels of subsets of target mRNAs.Entities:
Mesh:
Substances:
Year: 2008 PMID: 19033365 PMCID: PMC2615618 DOI: 10.1093/nar/gkn929
Source DB: PubMed Journal: Nucleic Acids Res ISSN: 0305-1048 Impact factor: 16.971
Figure 1.Sequence and structure of the predicted AUF1 signature motif, as identified among AUF1-associated transcripts. (A) Left, Schematic of the experimental approach. HeLa cell lysates were subjected to immunoprecipitation (IP) with either IgG or anti-AUF1 antibodies. The collections of RNAs isolated from each IP reaction were identified using microarrays [Materials and Methods section and (25)] and were used to identify a signature sequence shared by the transcripts. Right, representative AUF1 signals in IP samples, as detected by western blot analysis; Input, aliquot of lysate before IP; H.C., heavy immunoglobulin chain. (B) Probability matrix (graphic logo) of the AUF1 motif, elucidated from the array-derived experimental dataset, indicating the relative frequency with which each nucleotide is likely to be found at each position within the motif. (C) Specific sequence and secondary structure of eight representative examples of the AUF1 motif in specific mRNAs; the corresponding gene names are shown.
Putative AUF1 target mRNAs based on the presence of the AU-rich signature motif in the 3′UTR
| Position in 3′UTR | # hits | Name | Symbol | UniGene |
|---|---|---|---|---|
| 885–917, 1621–1694, 1768–1801, 2565–2594, 3285–3317, 3678–3748, 4480–4512 | 10 | Insulin-like growth factor 1 | IGF1 | Hs#S3218917 |
| 415–453, 1469–1501, 2035–2067, 2083–2115, 2224–2256, 2738–2770, 2825–2857 | 7 | Cathepsin S | CTSS | Hs#S1728864 |
| 866–898, 1632–1664, 2787–2819, 3215 3247, 3248–3280, 4460–4492 | 6 | Rhotekin 2 | RTKN2 | Hs#S4553519 |
| 301–333, 354–395, 1340–1370, 1385–1417, 1510–1542, 4407–4461 | 6 | Protocadherin 19 | PCDH19 | Hs#S4812509 |
| 61–93, 259–289, 433–465, 776–808, 1911–1946 | 5 | Stress–associated ER protein 1 | SERP1 | Hs#S2139162 |
| 20–52, 63–94, 116–147, 548–580, 1025–1072 | 5 | Matrin 3 | MATR3 | Hs#S3219061 |
| 779–810, 891–923, 981–1013, 1106–1138, 1611–1643 | 5 | Calcyphosphine 2 | CAPS2 | Hs#S3619535 |
| 474–513, 989–1021, 1472–1504, 1594–1666 | 4 | NAG14 protein | NAG14 | Hs#S3817889 |
| 108–144, 856–888, 1608–1652, 1791–1823 | 4 | Transmembrane protein 2 | TMEM2 | Hs#S2138764 |
| 264–296, 1073–1104, 1111–1143, 1331–1363 | 4 | Calnexin | CANX | Hs#S3218949 |
| 87–122, 424–456, 485–584 | 3 | Chemokine (C–C motif) ligand 8 | CCL8 | Hs#S1730823 |
| 120–150, 550–582, 982–1081 | 3 | Sorting nexin 13 | SNX13 | Hs#S4001833 |
| 1261–1312, 2067–2099, 2183–2215 | 3 | CGI–149 protein | CGI–149 | Hs#S2140320 |
| 724–756, 1112–1143, 1664–1724 | 3 | RAB23, RAS oncogene family | RAB23 | Hs#S2140367 |
| 753–784, 1156–1255 | 2 | Villin 2 | VIL2 | Hs#S1728180 |
| 173–272 | 1 | Cytochrome c–1 | CYC1 | Hs#S1726589 |
| 255–354 | 1 | Aquaporin 11 | AQP11 | Hs#S7089975 |
| 462–561 | 1 | Huntingtin interacting protein C | HYPC | Hs#S15644799 |
| 71–170 | 1 | Cleavage/polyadenylation factor 3 | CPSF3 | Hs#S2140592 |
| 1353–1452 | 1 | Extracellular signal–regulated kinase 8 | ERK8 | Hs#S4435687 |
Partial list of genes bearing the AU–rich signature motif (Figure 1) in the 3′UTR of the corresponding transcripts. The complete list of predicted target transcripts is available (Supplementary Table S2). The relative position(s) and number of the AU–rich motif hits in the 3′UTR of each transcript are indicated.
Reported AUF1 target mRNAs bearing the AU–rich signature motif
| Position in 3′UTR | # hits | Name | Symbol | UniGene | Reference |
|---|---|---|---|---|---|
| 410–442, 1378–1411, 1581–1615 | 3 | Cyclin D1 | CCND1 | Hs#S3987156 | ( |
| 45–99 | 1 | Cyclin B1 | CCNB1 | Hs#S3618391 | (unpublished) |
| 291–326, 457–488 | 2 | Gadd45A | GADD45A | Hs#S1731372 | ( |
| 492–529, 592–624 | 2 | p16 | CDKN2A | Hs#S4001849 | ( |
| 210–248 | 1 | IL8 | IL8 | Hs#S3218902 | ( |
| 648–680 | 1 | TNFa | TNF | Hs#S3218906 | ( |
| 1783–1831, 2389–2429 | 2 | Estrogen receptor a | ESR1 | Hs#S1726719 | ( |
| 423–454 | 1 | TS | TS | Hs#S1728128 | ( |
| 939–970, 1433–1473, 1807–1840, 1885–1917, 2189–2220 | 5 | Cyclooxygenase–2 | PTGS2 | Hs#S1730801 | ( |
| 227–265, 3976–4013, 4373–4407, 4957–4989 | 4 | Bcl–2 | BCL2 | Hs#S1730182 | ( |
List of known AUF1 target mRNAs, out of a total of 15 best–characterized AUF1 target mRNAs previously reported. The positions of the motif hits within the 3′UTRs are indicated. Overlapping motifs are listed as one.
Figure 2.Analysis of the association of AUF1 with predicted target mRNAs bearing AU-rich motif. (A) Analysis of the interaction between AUF1 and 10 putative target transcripts chosen randomly from Table 1. Following RNP IP, the association of putative target mRNAs with AUF1 in whole-cell (‘Total’) HeLa cell lysates was assessed by monitoring the enrichment of the mRNAs in AUF1 IP samples relative to IgG IP samples. Conventional PCR (top, gel images) and real-time, quantitative (q)PCR (bottom, graph) were used to quantify this enrichment. In the qPCR analysis, the levels of housekeeping GAPDH mRNA were used to normalize differences in sample input. (B) RNP IP analyses were conducted as described in the legend of Figure 2A, except that cytoplasmic lysates (top graph, ‘Cytopl. mRNA’) and nuclear lysates (bottom graph, ‘Pre-mRNA’) were used. For pre-mRNA detection, specific primer pairs were used to amplify DNA regions that spanned intron–exon junctions. In (A) and (B), negative control transcripts (‘Neg. controls’) not AUF1 targets) are depicted as white bars. In (A) and (B), the graphed data show the means + the standard error of the means (SEM) from three independent measurements.
Figure 3.Schematic of the RNA segments spanning sections of the 3′UTRs of putative AUF1 target mRNAs that were amplified and used as templates for in vitro transcription in the presence of biotinylated CTP (Materials and methods section). The amplified regions contained one or several AUF1 motif hits; the complete number of hits is shown in Table 1; all numbers refer to positions within the 3′UTR. The biotinylated transcripts were incubated with HeLa cytoplasmic lysates or nuclear lysates and the presence of AUF1 in the resulting RNP complexes was tested by western blot analysis. Biotinylated transcripts spanning the p53 coding region (p53CR) and the GAPDH 3′UTR as well as beads without biotinylated RNA were included as controls to detect background signals.
Figure 4.Effect of silencing AUF1 on the steady-state levels of target mRNAs. (A) The levels of AUF1 in HeLa cells were monitored by western blot analysis 48 h after transfection with either a plasmid that expressed a silencing hairpin (sh) targetting AUF1 (pSIL-AUF1shRNA) or a control plasmid pSILENCER (pSIL). The relative intensities of the combined AUF1 signals, calculated after densitometry analysis, are indicated. (B) Forty-eight hours after silencing as described in (A), the steady-state levels of AUF1 target mRNAs (left), normalization control 18S rRNA, positive control CCND1 (cyclin D1, ‘Pos.’) and negative controls (‘Neg.’), were measured by RT–qPCR analysis. The data show the means and SEM from three independent experiments.
Figure 5.Effect of overexpressing AUF1 on the steady-state levels of target mRNAs. (A) The levels of AUF1 in HeLa cells were monitored by western blot analysis 48 h after transfection with a cocktail of plasmids that expressed p37, p40, p42 and p45 (collectively shown as pCDNA-AUF1) or with a control plasmid (pCDNA). The relative intensities of the combined AUF1 signals, calculated after densitometry analysis, are indicated. (B) Forty-eight hours after AUF1 overexpression as described in (A), the steady-state levels of AUF1 target mRNAs (left), normalization control 18S rRNA, positive control CCND1 (cyclin D1, ‘Pos.’) and negative controls (‘Neg.’), were measured by RT–qPCR analysis. The data show the means and SEM from three independent experiments.